Our results indicate that GLUT1 expression and activity is essential for the maintenance of the self-renewal and tumor-initiating capacity of CSCs, suggesting that CSC maintenance may be among the critical roles of increased glucose metabolism of cancer cells and that GLUT1 could be a promising molecular target in CSC-directed cancer therapies. The gene discussed is SLC2A1; the disease is cancer.